The patient, a 42-year-old Ugandan-born national residing in Abuja, tested positive for the Bundibugyo species of the Ebola virus on 20 October. She is the wife of a Swiss diplomat, whose status was confirmed by the Swiss Foreign Ministry. According to Swiss officials, the woman spent approximately two and a half weeks in Uganda before returning to Nigeria on 3 October. She developed symptoms four days after her arrival and sought treatment at two private health facilities in Abuja before being diagnosed. Her husband is currently in isolation but has not developed symptoms, and Swiss authorities stated that the 25 staff members at the embassy in Nigeria remain healthy and do not require isolation, a decision made in consultation with Nigeria’s Ministry of Health and the World Health Organization (WHO).
Health authorities in Nigeria, the WHO, and the Africa Centres for Disease Control and Prevention (Africa CDC) are investigating whether this case is linked to the first Ebola death recorded in Kenya. The Kenyan victim, a man who arrived in Nairobi from the Democratic Republic of Congo (DRC) on 3 October, died shortly after arriving. Investigators are examining the possibility that the two patients crossed paths in Uganda, specifically at Entebbe airport, or through shared equipment. Dr Wessam Mankoula, head of emergency preparedness and response at the Africa CDC, described this as “one of the possible scenarios” but stressed that no link had been established. Nigeria’s Centre for Disease Control and Prevention (NCDC) is prioritizing genomic sequencing to determine if the viral strains are identical, which could help establish the source of infection.
Significant contradictions exist regarding the patient’s travel history. While Ugandan health officials previously stated that the woman had traveled to eastern DRC for business, the Swiss government, WHO, and Nigeria’s health ministry have stated they have not received verified information confirming this claim. The Swiss government explicitly told Reuters that the patient did not travel to the DRC. This discrepancy highlights the difficulty in reconstructing the full exposure history, a challenge compounded by the patient’s initial treatment in private facilities rather than a designated isolation center.
The situation in Kenya, where the outbreak was first detected, remains under close control. The health ministry reported a second death on 13 October, a 65-year-old woman who was a close family member of the first victim. Seven other patients, including three relatives of the first victim, three health workers, and a hospital cleaner, were receiving treatment at two isolation facilities. The ministry emphasized that all cases were within “one cluster, with no evidence of community spread.” Kenya has implemented enhanced screening for travelers arriving from the DRC and eight other high-risk countries, including Uganda. Travelers must now complete a digital surveillance form and present a QR code to port health officials upon arrival.
The broader context of this regional alert is the ongoing Ebola outbreak in the DRC, which has become the second most deadly in history, with more than 4,000 deaths recorded since the disease was confirmed in May. The Bundibugyo species of Ebola, the strain identified in both Kenya and Nigeria, is relatively rare compared to the Zaire species. Currently, there is no approved vaccine or specific treatment for the Bundibugyo strain, although clinical trials are underway. The virus spreads through contact with infected bodily fluids, such as blood or vomit, and can lead to organ failure and, in some cases, internal and external bleeding.
Public health officials are urging caution without causing panic. In response to the risk of imported cases, the United States has warned its citizens against traveling to Kenya, while neighboring countries including Uganda, Ethiopia, and Somalia have heightened their alert levels. Uganda has also banned transits for individuals who have recently visited the DRC. As genomic sequencing results from Nigeria’s case are processed, the international community awaits confirmation of whether this represents a new cluster or an isolated importation event linked to the Kenyan case. The clarity of this epidemiological link will be critical in determining the necessary scale of the public health response across the region.
